Results 171 to 180 of about 6,278 (225)
Some of the next articles are maybe not open access.

ORAL ANTIDIABETIC THERAPY

Annals of Internal Medicine, 1959
Excerpt There is some evidence suggesting that the majority of patients with diabetes have subnormal concentrations of insulin in the plasma, but a hypernormal quantity of insulin has been demonstr...
R H, WILLIAMS   +3 more
openaire   +2 more sources

Antidiabetic Agents

Primary Care: Clinics in Office Practice, 1990
Although either insulin or oral hypoglycemics may be used in conjunction with diet and exercise in the management of type II diabetes, drug therapy for type I diabetes involves only insulin. C-peptide levels can be tested to assess whether the patient has remaining pancreatic endocrine function.
openaire   +2 more sources

Antidiabetic Behavior of Biguanides

Journal of Pharmaceutical Sciences, 1983
The existence of active electron pairs on some nitrogen atoms in phenformin hydrochloride is inferred from the presence of a hydrogen catalytic polarographic wave. This finding emphasizes the ability of biguanides to form hydrogen bridges with other molecular species such as amino acids and proteins, as well as to form coordination complexes with zinc ...
F, Vicente-Pedrós   +2 more
openaire   +2 more sources

Diabesity and antidiabetic drugs

Molecular Aspects of Medicine, 2019
The prevalence of "diabesity" - diabetes related to obesity - has increased tremendously over the past few decades because of the global obesity epidemic. Although bariatric surgery is the best treatment option for patients with diabesity, a majority of patients are managed only with antidiabetic drugs for various reasons.
Joseph M. Pappachan   +2 more
openaire   +2 more sources

Screening for Antidiabetic Activities

2013
Screening extracts and drug entities for antidiabetic bioactivity is essentially limited to animal models as the processes leading to hyperglycemia and the complications of diabetes involve more than one organ. Further, in vitro results seldom translate into meaningful in vivo outcomes especially in a disease such as Diabetes Mellitus.
Caccetta, Rima, Al Salami, H.
openaire   +3 more sources

Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview

International Journal of Research in Pharmacy and Allied Science
Diabetes mellitus—particularly type 2 diabetes (T2DM)—is increasing rapidly in India and poses significant social and economic challenges. Alongside conventional pharmacotherapy, herbal formulations from Ayurveda and traditional medicine are widely used for glycemic management.
M.Y. Mohammad Ismail, Dr. A. B Roge
openaire   +1 more source

Antidiabetic Agents and Lactation

Journal of Human Lactation, 1992
If the dose of insulin and adequate carbohydrate intake is ensured, most diabetic mothers taking insulin will be able to breastfeed satisfactorily. Compared to the dose before pregnancy, the required insulin dose probably will be substantially reduced during breastfeeding.
openaire   +2 more sources

Troglitazone: an antidiabetic agent

American Journal of Health-System Pharmacy, 1998
The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of troglitazone are reviewed. Troglitazone is the first oral thiazolidinedione approved for use in treating non-insulin-dependent diabetes mellitus (NIDDM). The drug's mechanism of action has not been fully elucidated.
openaire   +2 more sources

Antidiabetics

Reactions Weekly, 2022
openaire   +1 more source

Home - About - Disclaimer - Privacy